Staphylex

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Staphylex

Quick Facts

Property Description
Active ingredient Flucloxacillin (typically as the sodium salt)
Form Capsule, oral solution, powder for injection
Pharmacological class beta-Lactam Antibiotic, Penicillinase-Resistant
General use Countering systemic bacterial infections
Origin Semisynthetic

What Type of Medicine is Staphylex (Flucloxacillin)?

Staphylex is a specific brand name for the antibiotic Flucloxacillin, which belongs to the penicillin family of anti-infective agents. It is formally classified as a semisynthetic beta-Lactam antibiotic.

Its key distinguishing feature is its categorization as a penicillinase-resistant penicillin. This means its molecular structure is protected against the destructive enzymes (beta-lactamase) often produced by certain bacteria, notably Staphylococcus species. This class is effective against such resistant organisms, making it a critical choice when these defenses are present.


Composition, Origin, and Available Forms

Staphylex is a single-component product whose entire therapeutic action is provided by its active ingredient, Flucloxacillin. The drug is of semisynthetic origin, manufactured via chemical modification of the natural penicillin core to enhance its stability and resistance profile.

To accommodate both adults and pediatric patients, Staphylex is manufactured in multiple dosage forms. These typically include the capsule for oral consumption and an oral solution or suspension designed for those who require liquid medication. It is also available as a sterile powder for solution for injection for delivery in a hospital setting.


How Does Flucloxacillin Generally Work?

Flucloxacillin works primarily through a bactericidal effect, meaning its fundamental purpose is to actively kill susceptible bacteria causing the infection.

This is achieved by disrupting a process essential for the pathogen's survival: bacterial cell wall synthesis. By interfering with this construction, the drug causes the structural integrity of the bacterial cell to fail. This direct, lethal mechanism, combined with its established resistance, underpins its general therapeutic purpose: the effective clearance of bacterial diseases caused by susceptible organisms.

Regulatory References

  1. Dicloxacillin: MedlinePlus Drug Information

What side effects are possible with Staphylex?

Possible Side Effects and Safety Information

The safety profile of Flucloxacillin (Staphylex) is officially documented by regulatory authorities, classifying potential reactions by frequency and affected body system. This section outlines the spectrum of officially listed adverse effects and key safety considerations, strictly based on regulatory documents.

Adverse Reaction Categories and Frequency

Adverse reactions are classified using standard frequency categories:

  • Common (affecting up to 1 in 10 people): Generally minor gastrointestinal disturbances, such as diarrhea, nausea, or stomach upset.
  • Uncommon (affecting up to 1 in 100 people): Skin reactions like pruritus (itching) and rash (urticaria).
  • Rare to Very Rare (affecting fewer than 1 in 1,000 people): Includes severe hepatobiliary disorders (cholestatic jaundice, hepatitis), blood and lymphatic system disorders (e.g., agranulocytosis), and severe skin and subcutaneous tissue disorders (Stevens-Johnson syndrome, Toxic Epidermal Necrolysis).

Serious Adverse Reactions and Systemic Effects

Official labeling documents specific serious adverse reactions. Hepatotoxicity, which includes cholestatic jaundice and hepatitis, is an explicitly noted risk. The onset of these liver effects may be delayed, sometimes occurring weeks after treatment has stopped, and the risk is cited as higher with longer treatment duration. Anaphylaxis is listed as a rare but severe immune system disorder. The medication may rarely affect the renal system, causing interstitial nephritis.

Population-Specific Safety Considerations

Safety documents specify particular caution for certain groups. Older adults (e.g., those aged 55 years and above) and individuals with pre-existing hepatic impairment are identified as having an increased risk for severe liver reactions. The medicine is contraindicated in patients with a prior history of Flucloxacillin-associated jaundice or known allergy to penicillins. Monitoring of hepatic and renal function is sometimes recommended during prolonged courses of treatment.

Overdose and Emergency Response

Overdose and When to Seek Help

This information is based on official government regulatory labeling for Flucloxacillin (Staphylex) and describes the documented manifestations of overdose and the required emergency actions.

Classification Manifestations and Risks (Official Labeling)
Documented Manifestations Nausea, vomiting, and diarrhoea are commonly reported. High parenteral doses may lead to Central Nervous System (CNS) effects, including fits (convulsions/seizures), fever, and behaviour disorders. Specific laboratory changes, such as electrolyte disturbances and blood abnormalities (e.g., prolonged bleeding time), are also noted.
Severe Outcomes Neurotoxicity (encephalopathy) and severe haematological effects are serious risks, particularly with high doses in patients with impaired renal function. High Anion Gap Metabolic Acidosis (HAGMA) is documented when Flucloxacillin is taken concurrently with Paracetamol in at-risk individuals.
Population Notes Special caution is essential in newborns due to the risk of high serum levels and potential kernicterus in jaundiced babies.

Required Emergency Action

Official regulatory information mandates a very low threshold for intervention. If an overdose is suspected, the required action is to:

  • Immediately telephone a doctor or a Poisons Information Centre.
  • Go to the Accident and Emergency department at your nearest hospital.

Urgent medical attention must be sought even if there are no signs of discomfort or poisoning. Treatment is limited to symptomatic and supportive management, as no specific antidote is documented and the drug is not significantly removed by dialysis.

Therapeutic Uses of Staphylex

What Staphylex Treats: Main Uses and Benefits

Staphylex (Flucloxacillin) is generally used for its capacity to manage the conditions presenting with symptomatic distress, and may provide supportive relief by helping with symptoms related to physical discomfort. Its use is commonly centered on situations where bacterial pathogens, particularly penicillinase-producing Staphylococcus, cause significant illness. It is commonly used for a variety of bacterial infections.


Therapeutic Scope and Patient Benefit

This medication is considered relevant for addressing conditions marked by local tissue inflammation and systemic imbalance. Clinical scenarios often involve acute skin and soft tissue infections like spreading cellulitis, abscesses, and impetigo, as well as deeper challenges such as osteomyelitis (bone infection), infective endocarditis, and septicaemia. The medication helps address symptom clusters like pain, redness, swelling, and fever. For patients, the primary benefit is that it may assist with easing the overall symptom burden in conditions involving inflammatory or irritative states, and supports patients during difficult episodes by easing distress. It is also applied in specific contexts, such as providing short-term preventative support during or after major surgery.

“This application is commonly used to help with managing the potential for post-operative infection, which supports general well-being during symptomatic phases.”

Quick Fact: Relevant Symptom Focus

Domain Condition Focus Symptom Focus
Dermatology Skin and soft tissue infections (SSTIs) Localized pain, swelling, redness
Systemic Medicine Deep-seated conditions (e.g., septicaemia) Fever and systemic malaise

Eligibility and Restrictions for Use

Eligibility for Staphylex (Flucloxacillin)

The official regulatory eligibility for Staphylex is determined by two absolute prohibitions and conditional use rules based on patient health status and age.

Classification Population Restriction
Contraindicated Patients with a history of hypersensitivity to Flucloxacillin or any other beta-lactam antibiotics (penicillins, cephalosporins).
Contraindicated Patients with a previous history of Flucloxacillin-associated jaundice or hepatic dysfunction.
Conditional Use Patients with severe renal impairment (creatinine clearance < 10 ml/min) must have their dose or dosing interval modified.
Conditional Use Neonates require special caution due to the risk of hyperbilirubinaemia and potential for high serum levels.
Conditional Use Use in pregnancy and lactation is generally reserved for essential cases where benefits outweigh potential risks; breastfeeding may need to be discontinued.

Adults and children (typically ge 2 years) without contraindications are the standard eligible population. Use in older adults (ge 50 years) or those with serious underlying disease is advised with caution due to the heightened risk of liver-related events.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Staphylex (Flucloxacillin) has officially documented interaction patterns that influence either its own systemic exposure or the exposure and effects of co-administered medicines. The regulatory profile identifies several agents requiring caution or restrictions.

Interacting Substance Officially Documented Interaction Effect
Probenecid, Sulfinpyrazone Delay renal excretion of Flucloxacillin by inhibiting tubular secretion, resulting in enhanced plasma concentrations of the antibiotic.
Voriconazole Flucloxacillin acts as a CYP450 inducer, significantly decreasing Voriconazole plasma concentrations and potentially leading to a loss of effectiveness.
Methotrexate Reduces the excretion of Methotrexate, increasing the risk of Methotrexate toxicity.
Paracetamol (Acetaminophen) Co-administration is associated with an increased risk of High Anion Gap Metabolic Acidosis (HAGMA), particularly in patients with severe renal impairment, sepsis, or malnutrition.
Oral Anticoagulants (e.g., Warfarin) Reports note increased anticoagulant effect and altered International Normalised Ratio (INR), requiring careful monitoring.
Bacteriostatic Antibiotics May interfere with the bactericidal effect of Flucloxacillin in scenarios requiring a rapid bactericidal outcome.
Food (Oral form) Oral administration must occur in a fasting state to achieve optimal peak serum concentrations.

Additionally, procedural restrictions mandate that the intravenous solution must not be mixed with Aminoglycosides or certain IV fluids (e.g., blood products) due to physical incompatibility. The interaction profile is structured around these pharmacokinetic and pharmacodynamic consequences as documented in official prescribing information.

Mechanism of Action

Staphylex (flucloxacillin) is a beta-lactam antibiotic that exerts its action through two primary mechanistic domains, resulting in the disruption of critical bacterial cellular structures.

Inhibition of Bacterial Cell Wall Synthesis

This domain involves the drug's action as a structural analog that engages mechanisms regulating peptidoglycan synthesis within the bacterial cell. Staphylex binds covalently to and inactivates Penicillin-Binding Proteins (PBPs), which are transpeptidases essential for catalyzing the cross-linking of peptidoglycan chains in the bacterial cell wall. This initiates a signaling sequence that prevents the final step of cell wall assembly. The resulting physiological consequence is a structurally unsound cell wall, inducing osmotic instability.

Resistance to beta-Lactamase Enzymes

Staphylex possesses a chemical structure that provides steric hindrance due to its isoxazolyl side chain. This structure protects the core beta-lactam ring from hydrolysis by certain bacterial beta-lactamase enzymes (penicillinases). This contributes to sustaining the drug's molecular activity in the presence of these defense enzymes, thereby maintaining interaction with its targeted PBP pathways.

Dosage and Administration Information

How to Use Staphylex: Official Administration Guidelines

Staphylex (flucloxacillin) is administered according to strict dosage regimens and procedural guidelines established in regulatory documents to ensure proper use.


Administration Scope

Instruction Domain Official Requirement (Adult Dosing)
Route of Administration Oral (Capsules, Solution), Intravenous (IV), Intramuscular (IM), Intrapleural, and Intra-articular injection
Dosing Schedule (Routine) 250 mg to 500 mg every six hours (Q6H) for general use. Doses may be doubled in severe infections
Timing in Relation to Meals Oral doses must be taken on an empty stomach: either at least 60 minutes before a meal or at least 2 hours after eating to maximize absorption

Procedural and Population-Specific Instructions

Instruction Domain Official Requirement
Preparation Requirements Powder for injection requires reconstitution with a specific diluent (e.g., Water for Injections) for parenteral administration. IV injection should be given slowly (over 3-4 minutes) or as an infusion
Special Procedural Conditions Capsules must be swallowed whole with a full glass of water and should not be broken or chewed. Patients should not lie down immediately after taking the oral dose
Age/Impairment Rules Dosage is weight- or age-dependent in the pediatric population. In cases of severe renal failure (creatinine clearance <10 mL/min), a reduction in dose or extension of the dose interval must be considered, with the maximum recommended dose typically 1 g every 8 to 12 hours
Course Duration Use for surgical prophylaxis is typically limited to up to 72 hours. Treatment for deep-seated infections may require a prolonged course

The official instructions establish a precise protocol centered on maintaining consistent therapeutic concentration by strictly mandating the empty-stomach intake condition and the six-hourly frequency. This structure defines the standardized use of Staphylex across its various approved routes, with specific adjustments mandated for severe renal impairment.

Recent Clinical Evidence

Staphylex: Recent Clinical Evidence

Research Evidence for Skin and Soft Tissue Infections (SSTIs)

Research explored the use of Staphylex (Flucloxacillin) for conditions associated with acute or disruptive episodes, particularly skin and soft tissue infections (SSTIs) like cellulitis, abscesses, and wound infections. The evidence primarily comes from short-term Randomized Controlled Trials (RCTs), systematic reviews, and large-scale meta-analyses. These studies included a variety of patients, from adults to children, allowing researchers to observe responses over defined time intervals. Outcomes measured focused on changes in symptom patterns (such as the size and extent of the affected skin area), changes in systemic indicators like fever, and the need for subsequent antibiotic courses. Evidence quality varies across studies, and comparative evidence is lacking to distinguish treatment patterns between different first-line antibiotics.


Research Evidence for Serious Systemic and Deep-Seated Infections

Staphylex was studied for conditions associated with acute or disruptive episodes, including Staphylococcus aureus bacteraemia (a blood infection), osteomyelitis (bone infection), and infective endocarditis (a heart lining infection). The evidence base for these specific applications primarily consists of Retrospective Cohort Studies and prospective observational studies. Researchers monitored outcomes related to systemic or functional imbalance, including the frequency of relapse or hospital re-admission, long-term mortality, and microbiological measures. Certainty remains low for some aspects of treating deep-seated infections due to the scarcity of large, dedicated prospective randomized trials that explore the optimal duration and transition from intravenous to oral therapy, especially for conditions like osteomyelitis.


What Is Still Uncertain About Staphylex Research

Evidence contributes to the broader evidence landscape, and evidence highlights what is known — and what is still uncertain about the medicine. A key research limitation is that comparative evidence is lacking for certain uses, and the evidence quality varies across studies, particularly those concerning surgical prophylaxis. Data are still emerging, and research is ongoing, but certainty remains low regarding dosing for critically ill patients. Studies help show what has been observed so far, and research does not determine whether an individual will respond similarly; findings describe group patterns, not personal outcomes.

Key Studies & References

  1. Summary of the evidence | Cellulitis and erysipelas: antimicrobial prescribing - NICE Guideline NG141
  2. Decision making on the route and duration of antibiotic therapy in acute cellulitis (Systematic Review and Meta-analysis, Walker et al. 2020)
  3. Guidance on the management of Staphylococcus aureus bacteraemia (SAB) in adults (Scottish Antimicrobial Prescribing Group)
  4. Staphylococcus aureus | Johns Hopkins ABX Guide (Management of MSSA, Osteomyelitis, and Endocarditis)

Frequently Asked Questions (FAQ)

Common questions about Staphylex (FAQ)


Q: Is Staphylex the same as penicillin?

Staphylex is the brand name for the medicine Flucloxacillin, which is classified as a beta-lactam antibiotic and belongs to the penicillin group of medicines. Official sources indicate it is specifically a penicillinase-resistant penicillin. This specialized classification means it is active against certain bacteria that have developed resistance to standard penicillin.


Q: Is it normal to feel a bit nauseous after taking Staphylex?

Nausea and minor stomach upset are considered common side effects reported in official labeling, meaning they are experienced by up to 1 in 10 people. While this is a recognized occurrence, patients are generally advised to consult a healthcare professional regarding any side effects that are severe or concerning.


Q: Are there any common foods or drinks that interact with Staphylex?

The most important restriction involves food, as regulatory information mandates taking the oral form on an empty stomach to achieve optimal absorption. Official documents do not typically specify interactions with common non-alcoholic drinks like water or juice, but the timing relative to a meal is a required condition for use.


Q: Does Staphylex interact with ibuprofen or Tylenol (acetaminophen)?

Official interaction information notes a risk when Staphylex is taken with Paracetamol (Acetaminophen), particularly in individuals with certain risk factors like severe renal impairment. This combination has been associated with an increased risk of High Anion Gap Metabolic Acidosis. Ibuprofen is not explicitly listed as a documented interaction in the official prescribing information.


Q: Are there different strengths or forms of Staphylex available?

Yes, according to official product information, Staphylex is manufactured in different forms to suit various administration needs. These forms typically include capsules for oral use, an oral solution or suspension, and a sterile powder for solution for injection. Dosage for adults is determined by healthcare providers depending on the infection.


Q: How long does a typical course of Staphylex last?

The course duration for Staphylex is not standardized and depends on the specific infection being treated. Official guidelines state that use for surgical prophylaxis may be limited to 72 hours, while therapy for more serious or deep-seated infections often requires a prolonged course.


Q: Are there any long-term side effects associated with Staphylex use?

Regulatory documents cite a risk of severe liver damage, known as hepatotoxicity, which is associated with Staphylex. This risk is cited as higher with a longer treatment duration, and the onset of this reaction may be delayed, sometimes occurring weeks after the medicine has been discontinued.


Q: What are the official warnings listed for Staphylex?

Official product information lists several key warnings, including contraindications (absolute prohibitions for use) related to penicillin allergy and a prior history of Flucloxacillin-associated jaundice. Caution is also advised for older adults and individuals with pre-existing hepatic impairment due to the increased risk of liver-related adverse events.


Q: Has Staphylex been studied for treating chronic infections?

While Staphylex is primarily used for acute bacterial episodes, official documents indicate that treatment for certain deep-seated infections—such as bone (osteomyelitis) or heart lining (endocarditis) infections—may require a prolonged course of therapy. This prolonged use reflects the complexity of clearing these types of infections.


Q: Is Staphylex used for infections that are resistant to other antibiotics?

Yes, the primary feature of Staphylex is that it is a penicillinase-resistant penicillin, according to official sources. This specialized structure helps it specifically target and remain effective against common bacteria, particularly Staphylococcus species, that have developed resistance to basic penicillin-type drugs.


Q: Can I take Staphylex if I have a history of stomach problems like colitis?

Official safety information notes that antibiotics, including Staphylex, are rarely associated with pseudomembranous colitis, a serious form of bowel inflammation. While general gastrointestinal issues like diarrhea are common, patients with a history of serious stomach or bowel issues may have increased risks that warrant attention.


Q: What does 'contraindication' mean regarding Staphylex?

A contraindication is a term used in regulatory documents to describe conditions where the medicine must not be used because the risks significantly outweigh the potential benefits. For Staphylex, contraindications include a known allergy to penicillin medicines and a previous history of Flucloxacillin-associated jaundice.


Q: Are there any patient registries or ongoing studies for Staphylex?

Official sources confirm that regulatory authorities maintain ongoing systems for the collection of adverse reaction reports after the medicine is on the market. While this is a continuous monitoring effort, specific details regarding the existence of formal patient registries are not typically included in the official prescribing information.


Q: Is Staphylex approved for short-term use only?

Staphylex is used to treat acute bacterial infections, but its period of use is flexible based on the medical need. Regulatory guidance shows that while some uses, like surgical prophylaxis, are limited to 72 hours, other serious infections require a prolonged course of therapy.


Q: Why do doctors prescribe Staphylex instead of another antibiotic?

According to official sources, the prescribing rationale is often based on Staphylex's key feature as a penicillinase-resistant penicillin. This specialized structure helps it specifically target and remain effective against common bacteria, particularly Staphylococcus species, that have developed resistance to basic penicillin-type drugs.


Q: What is the general success rate mentioned in clinical trials for Staphylex?

Official regulatory documents describe the effectiveness of Staphylex based on various clinical trial outcomes, such as changes in symptoms and clearance of bacteria. However, official sources do not provide a single, general 'success rate' because the outcome varies widely depending on the type and severity of the specific infection being treated.


Q: What are the signs of a serious allergic reaction to Staphylex?

Official safety leaflets describe severe allergic reactions (anaphylaxis) as rare but serious events. Signs can include difficulty breathing, swelling of the face, lips, throat, or tongue, and the rapid development of a severe, itchy skin rash or hives.


Q: How quickly does Staphylex start working?

Official pharmacokinetic data from regulatory sources show that the maximum concentration of the drug in the bloodstream is typically reached 1 to 2 hours after taking the oral dose. The full clinical effect, however, depends on the type and severity of the infection.


Q: Can Staphylex treat a viral infection?

No, Staphylex is a bactericidal antibiotic that is specifically designed to kill susceptible bacteria. Official product information states that this medicine is not effective for treating viral infections, such as the common cold or flu.


Q: Can Staphylex cause drowsiness or make me sleepy?

Drowsiness or sleepiness is not commonly listed as a side effect in official regulatory documents. However, these documents do note that very rare effects on the central nervous system may occur, particularly when high doses are administered or in individuals with severe kidney impairment.


Q: What happens if I miss a dose of Staphylex?

The protocol found in patient information leaflets suggests that a missed dose should be taken as soon as it is remembered, unless it is nearly time for the next scheduled dose. The leaflet also specifies that a double dose should not be taken to make up for a single forgotten dose.


Q: Can Staphylex interact with birth control pills?

Official guidance indicates that Flucloxacillin is generally considered to have no significant interaction with most oral contraceptive pills. However, if the medicine causes vomiting or severe diarrhea, additional precautionary contraceptive measures may be advised.


Q: How long after I stop taking Staphylex will it stay in my system?

Staphylex is eliminated from the body relatively quickly. Official pharmacokinetic data shows that the drug has a short half-life of approximately 1 hour. Consequently, the vast majority of the medicine is usually cleared from the body within 5 to 6 hours after the final dose has been taken.


Q: What is the difference between Staphylex and dicloxacillin?

Regulatory data classifies both Staphylex (flucloxacillin) and dicloxacillin as penicillinase-resistant beta-lactam antibiotics. While they are different compounds, they are described in official sources as having generally similar indications and antibacterial activity.


Q: What should I do if my symptoms don't improve while taking Staphylex?

Patient information leaflets instruct that if symptoms of the infection do not begin to improve within a few days of starting treatment, or if the patient's general condition worsens, the patient is instructed to contact their prescribing doctor for advice.


Q: Can Staphylex be taken by someone who is diabetic?

Official sources do not list diabetes as a contraindication or absolute restriction for using Staphylex. However, a specific interaction risk involving the use of Staphylex with paracetamol (acetaminophen) is noted for patients with underlying risk factors like sepsis or malnutrition.


Q: Does Staphylex lose effectiveness over time?

Regulatory documents caution that the misuse of any antibiotic, including Staphylex, can contribute to the development of antibiotic resistance. This process means that the medicine may become less effective at treating infections over a period of time.


Q: Is Staphylex a strong antibiotic?

Official sources use specific terms to classify its action. Staphylex is defined as a bactericidal antibiotic, meaning its purpose is to actively kill susceptible bacteria. It is listed as having a narrow spectrum of activity, targeting specific types of bacteria, notably certain Staphylococcus species.


Q: Do regulatory agencies list Staphylex as a narrow or broad-spectrum antibiotic?

Official regulatory documents, such as the SmPC, classify Staphylex as a narrow-spectrum beta-lactam antibiotic. This indicates that it is primarily effective against a specific, limited range of bacterial types.


Q: Can Staphylex make you sensitive to the sun?

Increased sensitivity to sunlight, known as photosensitivity, is not typically listed among the reported side effects in the official safety profile for Staphylex.


Q: What if I take Staphylex and drink alcohol?

Official prescribing information does not contain a specific warning against the consumption of alcohol while taking Staphylex, as it is not known to cause the severe adverse reaction sometimes associated with other antibiotics and alcohol.


Q: Does Staphylex require a prescription in most countries?

Yes, Staphylex (Flucloxacillin) is consistently categorized as a Prescription Only Medicine (POM) across most major regulatory jurisdictions worldwide. This classification indicates that it must be prescribed by a licensed healthcare professional.


Q: Is Staphylex known to cause yeast infections?

Official documents do not specifically list yeast infections (candidiasis) as a reported side effect. However, a general warning is noted that antibiotic use can sometimes lead to the overgrowth of non-susceptible organisms within the body.


Q: How is Staphylex different from cephalexin (Keflex)?

Official classification shows that Staphylex belongs to the penicillin class of antibiotics, while cephalexin belongs to the cephalosporin class. While both are beta-lactam antibiotics, regulatory documents do not provide a direct comparison between the two medicines.


Q: Does Staphylex have a risk of C. difficile-associated diarrhea?

Yes, official safety information indicates that, like most antibiotics, Staphylex carries a rare but serious risk of causing an inflammation of the bowel known as pseudomembranous colitis. This condition is often associated with the Clostridioides difficile bacteria.


Q: Is Staphylex related to sulfa drugs?

No, Staphylex is classified as a beta-lactam antibiotic and a member of the penicillin class. Official sources confirm that this medicine is not related to the class of medicines known as sulfa (sulfonamide) drugs.


Q: Are mental side effects, like confusion, possible with Staphylex?

Mental or neurological side effects, such as confusion, are not commonly listed in the official safety profile. However, regulatory documents state that very rare and severe central nervous system effects may occur, primarily when the medicine is administered in very high doses or to patients with pre-existing kidney impairment.


Q: How long does it take to see the maximum effect of Staphylex?

Official pharmacokinetic information from regulatory sources states that the maximum concentration of the drug in the bloodstream is typically achieved 1 to 2 hours after the oral dose is taken. This concentration is essential for the drug’s effectiveness.


Q: Is it necessary to complete the full course of Staphylex even if I feel better?

Patient information leaflets consistently emphasize the importance of completing the full prescribed course of medicine, even if symptoms have improved or disappeared. Completing the full course helps ensure the infection is completely cleared and is a key measure to help prevent the development of antibiotic-resistant bacteria.

How should Staphylex be stored and disposed of?

Storage and Disposal Requirements

Staphylex (flucloxacillin) must be stored and disposed of according to specific requirements detailed in official regulatory documents to maintain drug stability and ensure safety.

Storage Conditions

Requirement Official Instruction
Temperature Store below 25 C in a cool, dry place.
Environment Protect from moisture and excessive heat.
Packaging Keep in the original container and in its pack until the time of use.
Child Safety Must be kept out of the sight and reach of children.

Disposal Instructions

Staphylex must not be used after the expiry date. The unused or expired medicine must not be thrown away via household waste or wastewater. For proper disposal, the product should be returned to a pharmacist or pharmaceutical waste collection point.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Staphylex found in:

A-Z Index: